Don’t invest unless you’re prepared to lose all the money you invest. This is a high‑risk investment and you are unlikely to be protected if something goes wrong. Take 2 mins to learn more. 

Invest in High Impact Innovation in the South & South West

Invest with us
Apply for funding

The region’s universities invest £790m a year into R&D, yet spinouts are underfunded. We’re here to change that.

The UK is ranked 4th globally for tech, digital, and science-based innovation, the sectors that drive a thriving modern economy. Yet historically it has failed to turn its world leading research into commercial success. When it does, the benefit is often lost overseas. To accelerate economic growth and create high-skilled jobs, the UK needs to channel risk capital and business expertise into these high-growth, innovative sectors.

In the past decade, the Golden Triangle universities have been highly successful at building commercialisation ecosystems around the pipeline of IP they have been producing.   They have delivered strong returns for early-stage equity investors and substantial demand for infrastructure and real estate assets.

Combined, the research-intensive universities and institutions in the UK’s South & West invest £600m year in R&D, equivalent to Oxford and Cambridge. Yet, startups in the region raise 5x less at early stages than in the Golden Triangle, leaving valuable IP underfunded.

 

We are entrepreneurs, scientists, engineers, investors and operators passionate about helping to build and bring ideas to market.

We help guide early stage founders making the most of local capital, deep commercial expertise, and international networks.

We built QantX to ensure that high impact innovations developed in the South & West had the opportunity to stay in the region, creating high value jobs and raising the region’s economic opportunity and output.

Since 2019, we have invested in early-stage companies as angels before launching our first Fund in 2022. We are now scaling our vision of delivering long term economic benefit to the South & West through impactful innovation.

investments made

exits as Founders & Investors

acquisitions directly handled

companies supported

Investing to deliver a modern economy

The synergy between technology and entrepreneurial vision fuels economic progress by driving innovation, enhancing productivity, and creating new opportunities. This dynamic duo is essential for a resilient and forward-looking modern economy.

How we invest

Humanity’s insatiable demand for materials, land, food, and fuel is fuelled by a combination of population growth, urbanisation, economic development, and technological advancements. This relentless demand poses significant challenges in terms of sustainability, resource management, and environmental conservation.

We look for innovative solutions to help ensure a balanced and sustainable future.

Delivering modern health care requires a multifaceted approach that addresses various systemic, technological, and policy-related challenges.

We look for solutions ranging from novel biologics, improved point of care diagnostics, and better patient pathways across primary and secondary care.

Innovations rooted in substantial research and technological development, span diverse fields such as artificial intelligence, quantum computing, biotechnology, and advanced materials.

We look to support visionary academics and researchers developing the next generation of technologies.

Partnering with ambitious early stage Founders

“A career in academia doesn’t prepare you for what to expect in a commercial setting and it has been a pleasure to engage with the QantX team since 2020. Weekly catch-ups have helped us develop our commercial strategy and business model, as well as expanded our networks and build out our team. Their support has been critical in our mission to revolutionise diagnosis and prognosis of neurological conditions.”

Professor John Terry

Founder and CEO, Neuronostics

“QantX has been a valuable partner to SENISCA from the point of spinning out from the University of Exeter to where we are now, developing gamechanger oligonucleotide therapeutics for diseases with high unmet need and negotiating a global skin care deal incorporating our small molecule compounds. As an academic founder, it’s been a critical differentiator for us to have their expertise on hand to help build the right team, connect us with global leaders, and give us the confidence to develop our anti-senescence approaches.”

Professor Lorna Harries

Co-Founder and CSO, SENISCA

“QantX investors have been superbly helpful and supportive to EnsiliTech. They have been actively involved from the investment date and have facilitated important introductions and guided us through significant conversations with potential partners. We know that we have a strong ally, who is always on our side”.

 

 

Professor Asel Sartbaeva

Founder and CEO, Ensilitech

Backing high impact innovations solving global changes from the South & South West

Join us